期刊文献+

MiR-143通过负调控GLI3基因来抑制鼻咽癌细胞的迁移 被引量:6

MiR-143 inhibits migration of human nasopharyngeal carcinoma cells by negatively regulating GLI3 gene
暂未订购
导出
摘要 目的探讨miR-143在鼻咽癌细胞迁移中的生物学功能及可能的分子机制。方法应用生物信息软件预测miR-143靶基因,分别将预测靶基因GLI3的3'UTR及其突变体构建到荧光素酶载体psiCHECK-2骨架中。通过荧光素酶报告基因检测分析miR-143对靶基因GLI3的调控作用,并检测转染miR-143 mimics、inhibitor和siGLI3后鼻咽癌5-8F细胞miR-143和GLI3的表达水平及迁移能力的变化。结果生物信息学预测Hh信号通路转录基因GLI3可能是miR-143的靶基因;双荧光素酶报告基因分析表明miR-143能够作用于GLI3的3'UTR;Western Blot和qRT-PCR结果进一步证明5-8F细胞中miR-143与GLI3的表达呈负相关,并影响5-8F细胞的迁移能力。结论 MiR-143可通过负调控靶基因GLI3抑制鼻咽癌细胞的迁移,为进一步研究miR-143及Hh信号通路在鼻咽癌中的作用机制提供参考价值。 Objective To investigate the possible biological function and mechanism of miR- 143 in the metastasis of human nasopharyngeal carcinoma (NPC). Methods Using bioinformatics to predict the target gene of miR-143, the 3'UTR and mutant 3'UTR of GLI3 gene was cloned into psiCHECK- 2 vector. Dual- luciferase reporter gene assay was employed to examine the repression of the GLI3 gene. miR-143 and GLI3 expression levels in 5-8F cells transfected with miR-143 mimics, inhibitor, or siGLI3 were examined, and the changes in the cell migration ability was assessed by Transwell invasion assay. Results Bioinformatics prediction indicated the Hh pathway transcription gene GLI3 as a target gene of miR-143, and dual-luciferase reporter assay showed that miR-143 directly combined with the 3’UTR of GLI3. qRT-PCR and Western blotting demonstrated that the expression of miR- 143 in 5- 8F cells was negatively correlated to GLI3 and suppressed the migration of 5- 8F cells. Conclusion MiR-143 can inhibit the invasion of NPC cells by negative regulation of GLI3 gene, which sheds light on the role of miR-143 and Hh pathway in NPC.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第7期1057-1061,共5页 Journal of Southern Medical University
基金 广东省自然科学基金(S2011040003476) 广东省科技计划项目(2060303)
关键词 MIR-143 GLI3 双荧光素酶报告基因 5-8F 迁移 miR-143 GLI3 dual-luciferase reporter assay 5-8F cells migration
  • 相关文献

参考文献22

  • 1Chin D,Boyle GM,Porceddu S,et al. Head and neck cancer:Past,present and future [J].Expert Rev Anticancer Ther,2006,6:1111-8.
  • 2Lee AW,Foo W. Law SC,el al. Staging of nasopharyngealcarcinoma:From Ho'stothe new UICC system [J].Int J Cancer,1999,84(2):179-87.
  • 3Wang CJ,Zhou ZG,Wang L,et al. Clinicopathological significanceof microRNA-31,-143 and-145 expression in colorectal cancer[J].Dis Markers,2009,26(1):27-34.
  • 4Takagi T,Iio A,Nakagawa Y,et al. Decreased expression ofmicroRNA-143 and-145 in human gastric cancers [J].Oncology,2009,77(1):12-21.
  • 5Noguchi S,Mori T,Hoshino Y,et al. MicroRNA-143 functions as atumor suppressor in human bladder cancer T24 cells [J].CancerLett,2011,307(2):211-20.
  • 6Deftereos G,Corrie SR,Feng Q,et al. Expression of mir-21 andmir-143 in cervical specimens ranging from histologically normalthrough to invasive cervical cancer [J].PLoS One,2011,6(12):e28423.
  • 7Michael MZ,O'Connor SM,van Holst Pellekaan NG,et al.Reduced accumulation of specific microRNAs in colorectalneoplasia[J].Mol Cancer Res,2003,1(12):882-91.
  • 8PENG Xs,Wei GUO,LIU Tj,et al. Identification of miRs-143and-145 that is associated with bone metastasis of prostate cancerand involved in the regulation of EMT[J].PLoS One,2011,6(5):e20341.
  • 9Ambros V. The functions of animal microRNAs [J].Nature,2004,431(7006):350-5.
  • 10Doench JG,Petersen CP,Sharp PA. siRNAs can function as mi-RNAs[J].Genes Dev,2003,17(4):438-42.

同被引文献44

  • 1Xiao-Li Wu,Bin Cheng,Pei-Yuan Li,Huan-Jun Huang,Qiu Zhao,Zi-Li Dan,Dean Tian,Peng Zhang.MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2[J].World Journal of Gastroenterology,2013,19(43):7758-7765. 被引量:15
  • 2CATTO J W F, ALCARAZ A, BJARTELL A S, et al. Mi- croRNA in prostate, bladder, and kidney cancer: a system- atic review [ J ]. Eur Urol, 2011,59 (5) : 671-681.
  • 3CHEN X,GUO X,ZHANG H,et al. Role of miR-143 tar- geting KRAS in colorectal tumorigenesis [ J ]. Oncogene, 2009,28 (10) : 1385-1392.
  • 4XU B, NIU X, ZHANG X, et al. miR-143 decreases pros- tate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS [ J]. Mol Cell Biochem,2011,350( 1 ) :207-213.
  • 5MARCUCCI G, MAHARRY K S,METZELER K H,et al. Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently i- dentifies high-risk patients [ J]. J Clin Oncol 2013,31 (17) :2086-2093.
  • 6SONG S J, POLISENO L, SONG M S, et al. MieroRNA- antagonism regulates breast cancer stemness and metasta- sis via TET-family-dependent chromatin remodeling [ J ]. Ce11,2013,154(2) :311-324.
  • 7FANG R, XIAO T, FANG Z, et al. MicroRNA-143 ( miR- 143) regulates cancer glycolysis via targeting hexokinase 2gene[J].J Biol Chem ,2012 ,287 (27) :23227-23235.
  • 8MISALE S, YAEGER R, HOBOR S, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer [ J ]. Nature, 2012, 486 (7404) :532-536.
  • 9CHANG D Z, KUMAR V, MA Y, et al. Individualized therapies in colorectal caneer:KRAS as a marker for re- sponse to EGFR-targeted therapy [ J ]. J Hematol Oncol, 2009,2 ( 1 ) : 1 8-20.
  • 10Xiao-Ping Y,Jing H,Fei-Ping L,et al.Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma[J].JMagn Reson Imaging,2016,43(5):1179-1190.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部